ATRC

AtriCure (ATRC)

About AtriCure (ATRC)

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Details

Daily high
$27.65
Daily low
$27.32
Price at open
$27.56
52 Week High
$43.00
52 Week Low
$18.94
Market cap
1.3B
Dividend yield
0.00%
Volume
217,625
Avg. volume
517,047
P/E ratio
-32.07

AtriCure News

Details

Daily high
$27.65
Daily low
$27.32
Price at open
$27.56
52 Week High
$43.00
52 Week Low
$18.94
Market cap
1.3B
Dividend yield
0.00%
Volume
217,625
Avg. volume
517,047
P/E ratio
-32.07